Matches in Wikidata for { <http://www.wikidata.org/entity/Q104138912> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q104138912 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 9ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q104138912 description "artículu científicu espublizáu n'avientu de 2020" @default.
- Q104138912 description "scientific article published on 09 December 2020" @default.
- Q104138912 description "wetenschappelijk artikel" @default.
- Q104138912 description "наукова стаття, опублікована 9 грудня 2020" @default.
- Q104138912 name "Use of a High Protein Enteral Nutrition Formula to Increase Protein Delivery to Critically Ill Patients: A Randomized, Blinded, Parallel-group, Feasibility Trial" @default.
- Q104138912 name "Use of a High Protein Enteral Nutrition Formula to Increase Protein Delivery to Critically Ill Patients: A Randomized, Blinded, Parallel-group, Feasibility Trial" @default.
- Q104138912 name "Use of a High Protein Enteral Nutrition Formula to Increase Protein Delivery to Critically Ill Patients: A Randomized, Blinded, Parallel-group, Feasibility Trial" @default.
- Q104138912 type Item @default.
- Q104138912 label "Use of a High Protein Enteral Nutrition Formula to Increase Protein Delivery to Critically Ill Patients: A Randomized, Blinded, Parallel-group, Feasibility Trial" @default.
- Q104138912 label "Use of a High Protein Enteral Nutrition Formula to Increase Protein Delivery to Critically Ill Patients: A Randomized, Blinded, Parallel-group, Feasibility Trial" @default.
- Q104138912 label "Use of a High Protein Enteral Nutrition Formula to Increase Protein Delivery to Critically Ill Patients: A Randomized, Blinded, Parallel-group, Feasibility Trial" @default.
- Q104138912 prefLabel "Use of a High Protein Enteral Nutrition Formula to Increase Protein Delivery to Critically Ill Patients: A Randomized, Blinded, Parallel-group, Feasibility Trial" @default.
- Q104138912 prefLabel "Use of a High Protein Enteral Nutrition Formula to Increase Protein Delivery to Critically Ill Patients: A Randomized, Blinded, Parallel-group, Feasibility Trial" @default.
- Q104138912 prefLabel "Use of a High Protein Enteral Nutrition Formula to Increase Protein Delivery to Critically Ill Patients: A Randomized, Blinded, Parallel-group, Feasibility Trial" @default.
- Q104138912 P1433 Q104138912-5DB3F09B-9DC3-45B7-B1AE-275B65A40D38 @default.
- Q104138912 P1476 Q104138912-9D64B8F9-4982-4E9C-A423-CFEFB533EC67 @default.
- Q104138912 P2093 Q104138912-0ABC6B96-3310-46C1-96A2-D94DB70DF69B @default.
- Q104138912 P2093 Q104138912-24FDBD8C-D2F1-48F1-B3C5-DAADDFC15FC1 @default.
- Q104138912 P2093 Q104138912-2F0DC977-B767-42A9-A7B1-A5CE41E1FA71 @default.
- Q104138912 P2093 Q104138912-35FC93C2-DCAB-4620-9C61-FA6AB4779C51 @default.
- Q104138912 P2093 Q104138912-3747D66F-BE8C-4635-9869-EF75DAF074D1 @default.
- Q104138912 P2093 Q104138912-570F530A-8D38-4C51-9FB3-2AA5701DBC22 @default.
- Q104138912 P2093 Q104138912-719B3FA3-BC5C-46FC-A47C-A85C278B2AF9 @default.
- Q104138912 P2093 Q104138912-883BB243-10CE-4BC3-B729-F1FCC8436B3A @default.
- Q104138912 P2093 Q104138912-A71F2AFB-D577-477E-ABDB-BABD4BFDF932 @default.
- Q104138912 P2093 Q104138912-B452975B-B2FB-49D0-8F6C-2B98E407CDDA @default.
- Q104138912 P2093 Q104138912-C2D44447-E60A-4724-93CB-CB1D4B68BC18 @default.
- Q104138912 P2093 Q104138912-D9934DA4-3142-4ADE-B0C5-23DBB88A044A @default.
- Q104138912 P2093 Q104138912-FF9BAD32-0E5E-4FE9-9F2B-870B2AFF485B @default.
- Q104138912 P31 Q104138912-BE6ECB52-2F56-44E4-A061-BE92090ABA4C @default.
- Q104138912 P356 Q104138912-21C0CACA-6764-444E-9A01-879B1692852A @default.
- Q104138912 P50 Q104138912-3316C1F3-2B88-4486-966B-322441428241 @default.
- Q104138912 P50 Q104138912-A3EBDDDF-BC83-40B9-A6C8-D0C22AF9D4B9 @default.
- Q104138912 P50 Q104138912-F00C67C2-E04F-41E8-B69F-03BAACCC78FB @default.
- Q104138912 P50 Q104138912-F5C26FAC-DB53-4FC9-8F91-CE90FF40C6E4 @default.
- Q104138912 P577 Q104138912-2546B77E-246A-4D77-97E8-CA8952B59B66 @default.
- Q104138912 P698 Q104138912-B031EDB8-FAA6-4BE1-92DE-1B43BA1CC611 @default.
- Q104138912 P356 JPEN.2059 @default.
- Q104138912 P698 33296079 @default.
- Q104138912 P1433 Q6295717 @default.
- Q104138912 P1476 "Use of a High Protein Enteral Nutrition Formula to Increase Protein Delivery to Critically Ill Patients: A Randomized, Blinded, Parallel-group, Feasibility Trial" @default.
- Q104138912 P2093 "Andrew R Davies" @default.
- Q104138912 P2093 "Kylie Lange" @default.
- Q104138912 P2093 "Lorraine Little" @default.
- Q104138912 P2093 "Marianne J Chapman" @default.
- Q104138912 P2093 "Mark E Finnis" @default.
- Q104138912 P2093 "Matthew J Summers" @default.
- Q104138912 P2093 "Patricia J Williams" @default.
- Q104138912 P2093 "Paul J Young" @default.
- Q104138912 P2093 "Sally Hurford" @default.
- Q104138912 P2093 "Sandra L Peake" @default.
- Q104138912 P2093 "Stephanie N O'Connor" @default.
- Q104138912 P2093 "Suzie Ferrie" @default.
- Q104138912 P2093 "TARGET Investigator Collaborative and the ANZICS Clinical Trials Group" @default.
- Q104138912 P31 Q13442814 @default.
- Q104138912 P356 "10.1002/JPEN.2059" @default.
- Q104138912 P50 Q28321777 @default.
- Q104138912 P50 Q47618086 @default.
- Q104138912 P50 Q87416502 @default.
- Q104138912 P50 Q88310543 @default.
- Q104138912 P577 "2020-12-09T00:00:00Z" @default.
- Q104138912 P698 "33296079" @default.